Skip to main navigation Skip to search Skip to main content

Long-acting beta2-agonists for chronic obstructive pulmonary disease: Serious adverse events

  • Jan Brozek
  • , Elie A. Akl
  • , Roman Jaeschke
  • , Irene Terrenato
  • , Vincenzo Cilenti
  • , Mario Cazzola
  • , Leonardo Fabbri
  • , Paul O'Byrne
  • , Gordon H. Guyatt
  • , Holger Schünemann
  • IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
  • SUNY Buffalo
  • McMaster University
  • IRCCS Istituti fisioterapici ospitalieri - Istituto Regina Elena
  • University of Rome Tor Vergata
  • University of Modena and Reggio Emilia

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations
Original languageEnglish
Article numberCD007200
JournalCochrane database of systematic reviews (Online)
Issue number3
DOIs
StatePublished - 2008

Fingerprint

Dive into the research topics of 'Long-acting beta2-agonists for chronic obstructive pulmonary disease: Serious adverse events'. Together they form a unique fingerprint.

Cite this